Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
511.05
-0.85 (-0.17%)
BSENSE

Nov 20

BSE+NSE Vol: 16.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
191.35
177.28
187.28
166.32
163.36
154.07
168.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
191.35
177.28
187.28
166.32
163.36
154.07
168.18
Raw Material Cost
77.47
58.58
73.73
47.68
57.20
60.97
53.93
Purchase of Finished goods
26.86
20.93
16.45
25.03
21.72
15.83
14.75
(Increase) / Decrease In Stocks
-6.44
5.63
-1.10
3.25
-2.18
-7.42
11.48
Employee Cost
31.29
33.31
32.46
30.62
30.36
31.76
27.62
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
-0.01
0.00
0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
38.47
31.40
40.90
36.15
30.82
29.12
33.69
Total Expenditure (Excl Depreciation)
167.66
149.85
162.43
142.73
137.93
130.26
141.46
Operating Profit (PBDIT) excl Other Income
23.69
27.43
24.85
23.59
25.43
23.81
26.72
Other Income
9.53
24.26
-4.20
15.15
7.23
15.27
-6.88
Operating Profit (PBDIT)
33.22
51.69
20.65
38.74
32.66
39.08
19.84
Interest
0.32
0.26
0.27
0.30
0.23
0.21
0.37
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
32.90
51.43
20.38
38.44
32.43
38.87
19.47
Depreciation
3.88
3.88
3.68
3.72
3.62
3.48
3.23
Profit Before Tax
29.02
47.55
16.70
34.72
28.81
35.39
16.25
Tax
8.59
11.32
5.07
6.12
8.83
7.71
4.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.43
36.23
11.63
28.60
19.98
27.68
11.58
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.43
36.23
11.63
28.60
19.98
27.68
11.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.43
36.23
11.63
28.60
19.98
27.68
11.58
Equity Capital
20.03
20.03
20.03
20.03
20.03
20.03
20.03
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
10.2
18.09
5.81
14.28
9.98
13.82
5.78
Diluted Earnings per share
10.2
18.09
5.81
14.28
9.98
13.82
5.78
Operating Profit Margin (Excl OI)
12.38%
15.47%
13.27%
14.18%
15.57%
15.45%
15.89%
Gross Profit Margin
17.19%
29.01%
10.88%
23.11%
19.85%
25.23%
11.58%
PAT Margin
10.68%
20.44%
6.21%
17.2%
12.23%
17.97%
6.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 17.13% vs 1.33% in Sep 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2026 is 2.25% vs -24.12% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is -6.84% vs -10.36% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is 39.13% vs -34.29% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025

Compare Quarterly Results Of Lincoln Pharma. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
191.35
0
191.35
Other Operating Income
0.00
0.00
0.00
Total Operating income
191.35
0
191.35
Raw Material Cost
77.47
0
77.47
Purchase of Finished goods
26.86
0
26.86
(Increase) / Decrease In Stocks
-6.44
0
-6.44
Employee Cost
31.29
0
31.29
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
38.47
0.00
38.47
Total Expenditure (Excl Depreciation)
167.66
0
167.66
Operating Profit (PBDIT) excl Other Income
23.69
0.00
23.69
Other Income
9.53
0
9.53
Operating Profit (PBDIT)
33.22
0
33.22
Interest
0.32
0
0.32
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
32.90
0
32.90
Depreciation
3.88
0
3.88
Profit Before Tax
29.02
0
29.02
Tax
8.59
0
8.59
Provisions and contingencies
0.00
0
0.00
Profit After Tax
20.43
0
20.43
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
20.43
0
20.43
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.43
0
20.43
Equity Capital
20.03
0
20.03
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
10.20
0
10.20
Diluted Earnings per share
10.20
0
10.20
Operating Profit Margin (Excl OI)
12.38%
0%
0.00
12.38%
Gross Profit Margin
17.19%
0%
0.00
17.19%
PAT Margin
10.68%
0%
0.00
10.68%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 191.35 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 7.94% vs -5.34% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 17.13% vs 1.33% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.43 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -43.61% vs 211.52% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 2.25% vs -24.12% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.69 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -13.63% vs 10.38% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -6.84% vs -10.36% in Sep 2025

Quarterly - Interest
Interest 0.32 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 23.08% vs -3.70% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 39.13% vs -34.29% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.38%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025